Mazar Andrew Paul
SEC CIK 1727393 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | CSO, Dir | 22.6K | — | — | 10 | 2021-06-30 | 2022-03-31 |
Most active insiders at MNPR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Tsuchimoto Kim R | Dir | — | $911.1K |
| 2 | Anderson Raymond | Dir | — | $703.0K |
| 3 | KLAUSNER ARTHUR J | Dir | — | $343.9K |
| 4 | Vu Quan Anh | CFO | $104.9K | — |
| 5 | RIOUX PATRICE | Acting Chief Medical Off | — | $111.26 |
| 6 | Cittadine Andrew | COO | — | — |
| 7 | Hendricks Diane | 10% | — | — |
| 8 | Robinson Chandler | CEO, Dir | — | — |
Mazar Andrew Paul made no open-market trades at MNPR in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-01 | 2022-03-31 | MNPR | Monopar Therapeutics | Mazar Andrew Paul | CSO, Dir | M - OptEx | — | +1,606 | 22.6K | +8% | — |
| D | 2022-04-01 | 2022-03-31 | MNPR | Monopar Therapeutics | Mazar Andrew Paul | CSO, Dir | F - Tax | $2.55 | -471 | 22.1K | -2% | -$1,201 |
| D | 2022-01-04 | 2022-01-01 | MNPR | Monopar Therapeutics | Mazar Andrew Paul | CSO, Dir | F - Tax | $3.21 | -671 | 21.0K | -3% | -$2,154 |
| D | 2022-01-04 | 2022-01-01 | MNPR | Monopar Therapeutics | Mazar Andrew Paul | CSO, Dir | M - OptEx | — | +1,937 | 21.7K | +10% | — |
| D | 2022-01-04 | 2021-12-31 | MNPR | Monopar Therapeutics | Mazar Andrew Paul | CSO, Dir | M - OptEx | — | +1,606 | 20.3K | +9% | — |
| D | 2022-01-04 | 2021-12-31 | MNPR | Monopar Therapeutics | Mazar Andrew Paul | CSO, Dir | F - Tax | $3.21 | -556 | 19.7K | -3% | -$1,785 |
| D | 2021-10-01 | 2021-09-30 | MNPR | Monopar Therapeutics | Mazar Andrew Paul | CSO, Dir | F - Tax | $4.87 | -471 | 18.7K | -2% | -$2,294 |
| D | 2021-10-01 | 2021-09-30 | MNPR | Monopar Therapeutics | Mazar Andrew Paul | CSO, Dir | M - OptEx | — | +1,606 | 19.1K | +9% | — |
| D | 2021-07-02 | 2021-06-30 | MNPR | Monopar Therapeutics | Mazar Andrew Paul | CSO, Dir | F - Tax | $5.89 | -942 | 17.5K | -5% | -$5,548 |
| D | 2021-07-02 | 2021-06-30 | MNPR | Monopar Therapeutics | Mazar Andrew Paul | CSO, Dir | M - OptEx | — | +3,212 | 18.5K | +21% | — |
Purchase Sale Sale after option exercise All abbreviations